Medtronic is a global healthcare technology company that develops and sells device-based therapies and related services across cardiovascular, neuroscience, medical surgical and diabetes markets. It operates internationally and is incorporated in Ireland.
Medtronic reported interim Affera Sphere-9 data showing 65.5% of VT patients were free from recurrence at six months. The FDA granted Breakthrough Device designation for Sphere-9 and approved a U.S. pivotal IDE.
Healthcare stocks were described as a defensive sector facing 2026 reimbursement headwinds, while capex rankings showed HCA Healthcare, Johnson & Johnson and Merck at the top. The sources also highlighted how capex differs across providers, device makers and drug developers.
The FDA cleared MiniMed Flex, a screen-free insulin pump controlled by smartphone, and granted breakthrough device designation to Portal Diabetes’ implantable Portal Pump system. Portal Diabetes also began a Phase I study of Portal Insulin, while MiniMed said Flex supports its latest algorithm, sensors and infusion sets.
Intuitive Surgical disclosed that an unauthorized third party accessed internal IT business applications through a phishing incident, while Medtronic plans to lay off 81 employees from its Diabetes unit ahead of the MiniMed separation.
Medtronic's diabetes unit MiniMed is seeking up to $7.86 billion valuation in its U.S. IPO while cutting 81 jobs at its Northridge facility ahead of the planned separation into a standalone publicly traded company.
Medtronic announced FDA premarket approval for Infuse bone graft in transforaminal lumbar interbody fusion procedures at one or two levels from L2-S1, making it the only PMA-approved growth factor bone graft for ALIF, OLIF, and TLIF procedures.
Medtronic announced FDA clearance of the Stealth AXiS surgical system, a next-generation platform integrating planning, navigation, and robotics for spine surgery. The system features LiveAlign segmental tracking for real-time visualization.
U.S. regulators have received more than 1,400 reports since 2021 involving AI-enabled surgical devices, including allegations of botched surgeries and misidentified body parts. The FDA has authorized over 1,300 AI-integrated medical devices.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07602036 |
Type 2 Diabetes and Pregnancy a Single-arm Interventional Study |
NOT_YET_RECRUITING | NA |
| NCT07600502 |
Establish Whether Hyperangulated Videolaryngoscopy (HAVL) Can be Used to Facilitate Tracheal Intubation Effectively and Safely in Unselected Adult Patients; Describe the Population in Whom HAVL Fails to Facilitate Tracheal Intubation Successfully, Identifying Any Contributory Characteristics. |
NOT_YET_RECRUITING | NA |
| NCT07547306 |
Evaluation of Accelerated Bachmann Bundle Area Pacing in Heart Failure With Reduced ejectIon Fraction Who Have electrocarDioGraphic Evidence of Interatrial Block and Indicated for Implantable Cardioverter Defibrillator |
NOT_YET_RECRUITING | NA |
| NCT07546682 |
Propel Drug-Eluting Sinus Implant Family IBUKI Cohort |
RECRUITING | |
| NCT07545148 |
Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of Life |
NOT_YET_RECRUITING | |
| NCT07507422 |
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy |
RECRUITING | |
| NCT07479199 |
Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors |
RECRUITING | |
| NCT07432659 |
Add-On ZIDA Sock Therapy for Overactive Bladder |
RECRUITING | NA |
| NCT07384884 |
Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas |
NOT_YET_RECRUITING | NA |
| NCT07369310 |
Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming |
NOT_YET_RECRUITING | NA |
